Asymptomatic Myeloma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma (NCT02784483) | Yale University | 2017-02-10 |
Track Asymptomatic Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.